Scinai Immunotherapeutics (SCNI) Other Non-Current Liabilities (2017 - 2025)

Scinai Immunotherapeutics has disclosed Other Non-Current Liabilities across 8 years of filings, most recently posting $3000.0 for Q2 2025.

• Other Non-Current Liabilities for Q2 2025 came in at $3000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Jun 2025 was $3000.0 (changed 0.0% YoY), and the FY2024 annual result was $3000.0, down 96.88% from the prior year.
• Other Non-Current Liabilities came in at $3000.0 for Q2 2025 at Scinai Immunotherapeutics, roughly flat from $3000.0 in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $5.3 million in Q4 2022 to a low of $3000.0 in Q2 2024.
• The 4-year median for Other Non-Current Liabilities is $96000.0 (2023), against an average of $1.0 million.
• Across the five-year window, Other Non-Current Liabilities tumbled 99.67% in 2024 and changed 0.0% in 2025, its largest moves.
• Scinai Immunotherapeutics' Other Non-Current Liabilities stood at $5.3 million in 2022, then sank by 98.2% to $96000.0 in 2023, then slumped by 96.88% to $3000.0 in 2024, then changed by 0.0% to $3000.0 in 2025.
• The last three Other Non-Current Liabilities figures came in at $3000.0 (Q2 2025), $3000.0 (Q4 2024), and $3000.0 (Q3 2024), per Business Quant data.